NCT04097171 (DCAP) is a NA clinical trial of Diet in Endurance Cycling Performance, sponsored by Texas Christian University.

Who is sponsoring NCT04097171?

NCT04097171 is sponsored by Texas Christian University.

What drugs are being tested in NCT04097171?

Interventions in NCT04097171: Diet.

What condition does NCT04097171 study?

NCT04097171 studies Endurance Cycling Performance.

Is NCT04097171 still recruiting?

NCT04097171 is currently completed. Last updated 5 October 2021.

Last reviewed 2021-10-05 · How we verify

NCT04097171: DCAP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Diet Composition on Performance, Expenditure, Blood Lipids, and Appetite Hormones in Highly Trained Cyclists

Completed NA Last updated 5 October 2021

What this trial tests

NA trial testing Diet in Endurance Cycling Performance in 34 participants. Completed in 30 March 2020.

Timeline

11 November 2019

Primary endpoint
30 March 2020

30 March 2020

Quick facts

Lead sponsor	Texas Christian University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	basic science
Enrollment	34
Start date	11 November 2019
Primary completion	30 March 2020
Estimated completion	30 March 2020
Sites	1 location across United States

Drugs / interventions tested

Diet

Conditions studied

Endurance Cycling Performance — all drugs for Endurance Cycling Performance →

Sponsor

Texas Christian University

Who can join

Adults 18 to 65, any sex, with Endurance Cycling Performance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study employs a crossover design to evaluate the effect of two different diets (high carbohydrate vs. ketogenic) and corresponding test meals on endurance exercise performance, energy expenditure including resting metabolic rate and thermic effect of food, postprandial responses of blood lipids, glucose and appetite hormones, and cognitive function and mood states.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Changes in the chronic and postprandial blood lipid profiles of trained competitive cyclists and triathletes following a ketogenic diet: a randomized crossover trial.
Graybeal AJ, Kreutzer A, Moss K, Shah M. · · 2024 · cited 3× · PMID 38229197 · DOI 10.1186/s13102-023-00801-5
Chronic and Postprandial Metabolic Responses to a Ketogenic Diet Compared to High-Carbohydrate and Habitual Diets in Trained Competitive Cyclists and Triathletes: A Randomized Crossover Trial.
Graybeal AJ, Kreutzer A, Moss K, Rack P, et al · · 2023 · cited 3× · PMID 36673864 · DOI 10.3390/ijerph20021110

Verify or expand the search:

Other trials of Diet

Trials testing the same drug.

NCT07533513 — Effects and Mechanisms of Dietary Carbohydrate Intake and Quality on Glucose and Lipid Metabolism · NA · not yet recruiting
NCT07457827 — Effect of Low-Carbohydrate Versus Balanced Diets on Anthropometric Blood Pressure, ApoB, and hsCRP in Healthy Adults · NA · not yet recruiting
NCT07388589 — Soluble and Osmotic Fibre (SOLOS) Diet for Constipation · not yet recruiting
NCT07289672 — Food Limitations In Crohn's Disease and Ulcerative coliTis · NA · not yet recruiting
NCT07262112 — Efficacy of Resistance Exercise and an Anti-Inflammatory Diet on Pain, Disease Activity, Functional Status, and Quality · NA · not yet recruiting

Other Texas Christian University trials

Trials by the same sponsor.

NCT07271316 — Alii Supplement Study · Phase 2 · recruiting
NCT07377331 — Exploration of an Online Education Program to Support Caregivers' Knowledge Transfer · Phase 1 · recruiting
NCT07180446 — Can Gut Bacteria Predict Who Benefits Most From Exercise? A Gut Supplement to Help Exercise Non-Responders · NA · not yet recruiting
NCT07105826 — Impact of Prebiotic Sodas on Satiety and Metabolic Responses in Healthy Men · NA · recruiting
NCT07377318 — Project CARE-D - Online Caregiver Education for Dementia · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04097171 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Texas Christian University
Last refreshed: 5 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04097171.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing